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Abstract
Obese individuals are at greater risk for death from influenza virus infection. Paralleling human evidence, obese mice are
also more susceptible to influenza infection mortality. However, the underlying mechanisms driving greater influenza
severity in the obese remain unclear. Metabolic profiling has been utilized in infectious disease models to enhance
prognostic or diagnostic methods, and to gain insight into disease pathogenesis by providing a more global picture of
dynamic infection responses. Herein, metabolic profiling was used to develop a deeper understanding of the complex
processes contributing to impaired influenza protection in obese mice and to facilitate generation of new explanatory
hypotheses. Diet-induced obese and lean mice were infected with influenza A/Puerto Rico/8/34. 1H nuclear magnetic
resonance-based metabolic profiling of urine, feces, lung, liver, mesenteric white adipose tissue, bronchoalveolar lavage
fluid and serum revealed distinct metabolic signatures in infected obese mice, including perturbations in nucleotide,
vitamin, ketone body, amino acid, carbohydrate, choline and lipid metabolic pathways. Further, metabolic data was
integrated with immune analyses to obtain a more comprehensive understanding of potential immune-metabolic
interactions. Of interest, uncovered metabolic signatures in urine and feces allowed for discrimination of infection status in
both lean and obese mice at an early influenza time point, which holds prognostic and diagnostic implications for this
methodology. These results confirm that obesity causes distinct metabolic perturbations during influenza infection and
provide a basis for generation of new hypotheses and use of this methodology in detection of putative biomarkers and
metabolic patterns to predict influenza infection outcome.
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Introduction
Obesity has reached epidemic proportions [1]. Global approx-
imations report that two out of every three individuals are
clinically overweight (BMI$25–29.9) or obese (BMI$30) [2]. The
pathological complications of obesity are diverse and include co-
morbidities such as cardiovascular disease, type 2 diabetes, and
hypertension, to name a few [3,4]. Obese individuals are also more
susceptible to viral and bacterial infections [5]. In 2009, the
Centers for Disease Control and Prevention reported a high
prevalence of obesity among intensive care patients with
confirmed 2009 pandemic H1N1 influenza (pH1N1) infection
[6]. Several investigations have since established obesity as an
independent risk factor for enhanced pH1N1 [6–10] and seasonal
influenza infection severity [11–13]. Given that seasonal influenza
epidemics result in 250,000 to 500,000 deaths globally [14] and
future pandemics are likely imminent [15], understanding how
obesity enhances influenza severity is a global public health
concern.
We have previously shown that obese individuals exhibit
impaired cellular and humoral immune responses to influenza
vaccination [16]. Further, mouse models of obesity have
extensively demonstrated that obesity enhances influenza infection
mortality [17–23]. Both innate and adaptive influenza immune
defenses are altered by obesity, but elucidation of the underlying
mechanisms driving greater influenza severity in obese mice is
currently lacking [5,19–21,24]. Further, obesity is inherently a
metabolic disease, and thus far, no studies have considered how
dynamic changes in metabolism during influenza may impact
immunity and infection outcome in the obese.
Metabolic profiling, combining 1H nuclear magnetic resonance
(NMR) spectroscopy and multivariate statistical data analysis, has
found wide application in metabolic syndrome related diseases and
has also gained significant momentum in infectious diseases for
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discovery of predictive and diagnostic biomarkers [25–29].
Although few studies have utilized metabolic profiling to
investigate influenza pathogenesis, it has been reported that
infection with the mouse adapted strain, influenza A/FM/1/47,
caused distinct perturbations in fatty acid and amino acid
metabolism in the serum of infected mice compared with
uninfected mice [30]. In more recent years, the approach has
evolved towards a more systemic assessment of host responses, and
integrating immune measures has become established in particular
[31,32]. The purpose of this study was to develop a global view of
the impact of obesity on metabolism and immunity during
influenza infection and to generate data which can serve as the
basis for the formation of new mechanistic hypotheses and perhaps
new prognostic or diagnostic methodology.
In the present study, lean and obese mice were infected with a
mild dose of influenza A/PR/8/34 (H1N1) and subsequently
tissues and biofluids were harvested for metabolic profiling. 1H
NMR-based profiling revealed distinct metabolic signatures
between infected lean and obese mice. Interestingly, we identified
unique metabolic signatures in urine and fecal samples that
allowed for discrimination of infection status and distinguished
uninfected and infected lean and obese mice. Further, the
metabolic analysis was extended to include lung tissue, broncho-
alveolar lavage fluid (BALF), serum, mesenteric white adipose
tissue (WAT), and liver from infected lean and obese mice. We
detected significant alterations in ketone body, lipid, choline,
nucleotide, vitamin, amino acid and carbohydrate metabolic
pathways in influenza infected obese mice. We also analyzed T cell
populations from lean and obese infected mice to identify
immune-metabolic correlation structures, and several interactions
between a variety of metabolites and BAL or draining lymph node
T cell populations were uncovered. Identification of differential
metabolic signatures and immune-metabolic structures in lean and
obese mice facilitates the establishment of metabolic profiling as a
useful tool for characterizing influenza infection responses and
advances the current understanding of potential factors contrib-
uting to impaired influenza protection in obese mice.
Methods
Ethics Statement
Animal experiments were conducted at the University of North
Carolina at Chapel Hill Animal Facility, which is fully accredited
by the American Association for Accreditation of Laboratory
Animal Care. All mouse-related procedures were approved by the
University of North Carolina at Chapel Hill Institutional Animal
Care and Use Committee.
Animal Housing and Maintenance
Weanling, male, C57BL/6J mice (Jackson Laboratory, Bar
Harbor, ME) were housed under pathogen free conditions and fed
a high fat (45% kcal fat, Research Diets D12451) or low fat,
control diet (10% kcal fat, Research Diets D12450B, New
Brunswick, NJ) for 20 weeks.
Reagents
Phosphate buffer for 1H NMR acquisition of urine and extracts
was made at a D2O:H2O ratio of 1:1 at a pH of 7.4 containing
Na2HPO4 and NaH2PO4 (Sigma-Aldrich). D2O served as a field
frequency lock and sodium 3- (trimethylsilyl) [2,2,3,3-2H4]
propionate (Sigma-Aldrich) at 0.01% was added as a chemical
shift reference represented at d 0.0. For 1H NMR acquisition of
serum 0.9% saline was equally made up in 50% D2O (Sigma-
Aldrich). HPLC-grade water, chloroform, and methanol, for tissue
extractions were obtained from VWR International Ltd.
Influenza Infection and Sample Collection
Influenza A/Puerto Rico/8/1934 (H1N1, PR/8), (ATCC,
Manassas, VA), was propagated in 10–12 day old embryonated
chicken eggs as described previously [19,21]. At 72 h post-
infection, allantoic fluid was harvested, clarified by centrifugation
and then stored at 280uC [21]. For influenza inoculations, mice
were lightly anesthetized via isoflurane inhalation, and infected
with 1.16102 50% tissue culture infective dose (TCID50) PR/8 in
50 mL of phosphate buffered saline. The mice were infected via
non-invasive oropharyngeal aspiration, as similarly reported
[21,33,34]. Mice were sacrificed by cervical dislocation.
Urine and fecal samples for metabolic profiling were obtained at
three different time points: one day prior to infection (D-1), 2 and
6 days post-infection (dpi). Details regarding fecal/urine sample
collection are described elsewhere [27]. At 9 dpi, liver, lungs,
mesenteric (visceral) white adipose tissue (WAT), bronchoalveolar
lavage fluid (BALF) and mediastinal lymph nodes (mLN) were
harvested and further processed for flow cytometry or were flash
frozen in liquid nitrogen. Collection of BALF was performed as
previously described [19,21]. Urine, serum, fecal pellets, BALF,
liver, lung and WAT samples were shipped to Imperial College
London on dry ice for 1H NMR data acquisition and analysis.
Flow Cytometry
BAL and mLN cells were processed and stained for flow
cytometry as previously described [19,21] with the following
antibodies: CD16/32 (Fc blocker), CD4 (FITC), CD25 (PE-Cy7),
and Foxp3 (APC) from eBioscience (San Diego, CA); CD3 (APC/
Cy7) and CD8 (PerCP) from BioLegend (San Diego, CA). The
MHC class I tetramer (PE) specific for H-2Db-resricted epitope of
the influenza nucleoprotein (NP, DbNP366-74) of PR/8 was
obtained from the NIH Tetramer Core Facility (Atlanta, GA).
Stained cells were subsequently analyzed on a CyAn ADP
Analyzer flow cytometer (Beckman Coulter, Inc., Fullerton, CA),
and all flow cytometry data were analyzed via FlowJo Software
(TreeStar, Ashland, OR). All flow cytometry analysis of T cells
consisted of a doublet exclusion gate followed by gating of CD3+
cells for further analysis of CD4+ and CD8+ T cell populations.
Sample Preparation and Acquisition of 1H NMR Spectral
Data
Urine, feces, serum, and tissue samples were prepared according
to previously published protocols [27,35]. Individual BALF
samples (200 ml) were mixed with phosphate buffer (400 ml) and
550 ml of the mixture was subsequently transferred into 5 mm
diameter standard NMR tubes for data acquisition (Bruker
Biospin, Rheinstetten). All biological samples were analyzed using
a 600 MHz Avance DRX NMR spectrometer (Bruker; Rhein-
stetten), employing a standard one dimensional (1D) 1H NMR
Noesypr1d pulse sequence with water suppression (recycle delay
(rd)-90u-t1-90u-tm-90u-acquisition time) for all samples. Recycle
delay (rd) and mixing time (tm) were set to 2 s and 100 ms
respectively. For obtaining more comprehensive information on
the serum samples, two additional pulse programs were utilized
namely Carr-Purcell-Meiboom-Gill (cpmgpr) and diffusion edited
spectroscopy (ledbipolpr) [35]. The numbers of scans were
adjusted for each biological matrix, whereby urine and serum
were analyzed in 256 and extracts in 128 scans to obtain
maximum signal output. Data from each sample was accumulated
into 32 k data points within a spectral width of 20 ppm.
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Pre-processing of Spectral Data
Topspin 3.1 (Bruker Biospin) was utilized for partially pre-
processing of the raw spectra, including manual phasing, baseline
correction and calibration of the chemical shifts to the TSP signal
at d 0.00 or to the lactate doublet at 1.33 representing the CH3
signal, for serum samples. Spectra were subsequently imported
into a MATLAB interface (Mathworks Inc., USA) where regions
containing ethanol, methanol, urea, and water resonances were
cut out from the whole spectra. Selected regions were d 1.049–
1.232, d 3.599–3.7 (ethanol) for BALF spectra, d 4.704–6.318
(H2O and urea) for urine, d 3.332–3.443 (methanol), d 4.598–
5.001 (H2O) for serum, d 4.216–5.556 (H2O) for feces, d 4.723–
5.012 (H2O) for liver, d 4.713–5.075 (H2O) for lung, and d 4.675–
5.093 (H2O) for WAT. All remaining spectral regions were aligned
and normalized to the median spectrum according to an in-house
developed MATLAB script (Dr. Kirill Veselkov) [36].
Multi- and Uni-variate Data Treatment
Processed spectral data were exported to SIMCA-P software
(Umetrics, Sweden) for Principal component analysis (PCA) and
projection to latent structure discriminant analysis (PLS-DA) for
obtaining an overview on the data distribution and presence of
class differences [37,38]. For identification of the discriminatory
metabolites, orthogonal PLS-DA (O-PLS-DA) was applied using
an in-house developed script in MATLAB including a 7-fold cross
validation [39]. Metabolites that are related to a certain class are
represented by yellow to red colors in the color code included in
the O-PLS-DA plots, whereby the exact correlation value can be
extracted from the main plot in MATLAB. Here, only candidate
biomarkers above a correlation threshold corresponding to p#
0.05 were selected as significant.
In order to explore correlation structures between metabolic
data and T cell populations, an additional correlation analysis was
conducted. The spectral information which built the X-matrix was
therefore integrated with a second Y-matrix that contained the
flow cytometry data. The Pearson-based correlation script further
contained a peak picking algorithm to reduce inclusion of noise,
and a 10,000 fold permutation resulting in display of correlations
with p#0.05 only. Identity of peaks was confirmed by using in-
house NMR chemical shift database, Chenomx NMR suite
profiler software (Chenomx Inc, USA), and published 1H NMR
assignments [27,40,41]. Identities were further confirmed by using
statistical total correlation spectroscopy (STOCSY) in a MATLAB
environment [39].
Results
Metabolic Profiling Uncovers Distinct Metabolic
Perturbations in Influenza Infected Obese Mice
Weanling, male C57BL/6J mice were maintained on a high fat
(45% kcal fat) or a low fat, control diet (10% kcal fat) for 20 weeks.
Following the dietary exposure, obese mice weighed 33% more
Figure 1. Summary of influenza infection and metabolic profiling model. A) Weanling, male C57BL6/J mice were maintained on a high fat
(45% kcal fat) or low fat control diet (10% kcal fat) for 20 wks, n$9. B) Timeline of samples harvested for metabolic profiling. Lean and obese mice
were infected with 1.16102 TCID50 of influenza A/PR/8/34, and urine and feces were collected at -1 (uninfected mice), 2 and 6 dpi. Terminal samples
(mLN, BALF, serum, liver, WAT and lungs) were collected from the same cohort of mice at 9 dpi. Flow cytometry was used to enumerate BAL and mLN
T cell populations for immune-metabolic integration, n = 8–9. C) Absolute weight loss in lean and obese mice following PR/8 infection, n$9. D)
Percent weight loss normalized to pre-infection body weight, n$9. Values represent mean +SEM, ***p,0.0005 compared with lean mice.
doi:10.1371/journal.pone.0097238.g001
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than lean mice (Figure 1A). Figure 1B is a representative timeline
for collection of samples processed for immune-metabolic charac-
terization, and all samples were obtained from the same cohort of
lean and obese mice. Following the 20 wk dietary exposure, mice
were infected with 1.16102 TCID50 of PR/8. Although obese
mice lost more absolute weight compared with lean mice
(Figure 1C), there were no differences detected in percent weight
loss between the two groups (Figure 1D). It is well established that
obese mice are more likely to die from influenza if given a
sufficient viral dose [17–20,23]. However, we utilized a relatively
mild infection dose, as only 10% of lean and obese mice
succumbed to the infection. We chose a mild infection for this
model in order ensure that we captured metabolic changes
induced by obesity during infection rather than secondary
responses caused by lethal infection conditions.
We first set out to determine if metabolic profiling could
distinguish urine and fecal samples from uninfected and infected
lean and obese mice. We chose urine and feces because these are
biosamples that could easily be tested in humans. Further, we
chose to sample urine and feces at 2 dpi and 6 dpi to capture
metabolic changes during early and late infection responses.
Figure 2 represents a PCA scores plot showing clear separation of
naı̈ve (D-1) urine samples from early infection (D2) and later
infection (D6) time points for lean (Figure 2A) and obese mice
(Figure 2B). Pre-infection and 6 dpi samples were furthermore
combined in a PLS-DA analysis in order to capture whether
obesity status or infection state was the predominant influence to
the murine metabolic profile (Figure 2C). Of interest, all infection-
dietary groups displayed metabolically distinct urinary profiles.
Analysis of urinary and fecal metabolites differentially altered in
lean and obese mice during the infection revealed mixed effects in
a variety of metabolic processes, including perturbations in
nucleotide, vitamin, ketone body, carbohydrate, choline and lipid
metabolism (Table 1). Reflective of impaired glucose tolerance,
characteristic of obesity, obese mice had greater urinary glucose
levels prior to infection and throughout the course of the infection
[42,43]. Further, uninfected obese mice had significantly higher
concentrations of urinary taurine, ureidopropanoate, 1-methylni-
cotinamide, several unknown metabolites and lower levels of
trimethylamine. At 2 dpi ascorbate, ureidopropanoate and
acetylcarnitine were detected in the urine of obese mice, whereas
trimethylamine levels were greater in lean mice at -1 and 2 dpi.
Urinary 3-hydroxybutyrate concentration was greater at 6 dpi in
obese mice as well as several lipid metabolites in fecal extracts at 2
dpi.
The metabolic analysis was also extended to include assessments
of BALF, lung tissue, serum, liver and mesenteric WAT from lean
and obese mice at 9 dpi (Table 2). To limit variation within dietary
groups, due to intra-individual differences between mice, all
samples used for profiling were obtained from the same cohort of
mice. Although this is an inherent strength in our model, it limited
the analysis to one time period for harvesting terminal samples
(serum, WAT, BALF, lung and livers). We specifically chose BALF
and lung to examine local changes at the site of infection, and we
included peripheral tissues and serum to enhance understanding of
the systemic and global consequences of obesity during influenza.
Analyses of tissues at 9 dpi revealed that WAT showed the greatest
number of altered metabolites, whereby the majority of changes
were linked to amino acid metabolism (Table 2). Additionally,
serum showed a high degree of metabolic change between lean
and obese mice, including relatively higher general lipid levels in
the obese mice (Figure 3, Table 2). However, lean mice had
greater levels of serum acetone, 3-hydroxybutryate and acetate.
Lung and BALF did not show any significant differences between
lean and obese mice at 9 dpi.
Differential Immune-metabolic Correlations in Influenza
Infected Lean and Obese Mice
Metabolic profiling has previously been used to explore immune
regulatory systems during infections by applying multivariate
statistical methods to uncover metabolic-immune interactions
[32,44]. To further assess the co-variation between tissue/biofluid
metabolites and immune parameters in our model, a correlation
analysis was conducted between T cell population numbers and
1H NMR data for lean and obese statuses separately in order to
characterize the systemic background metabolism linked to T cell
responses. Although a variety of cellular defenses are altered by
obesity, we chose to focus our analysis on T cell populations
because this cell type is consistently altered by obesity during
influenza infection [17,19,21,24,45]. We have previously detected
perturbations in antigen specific CD8+ T cell and regulatory T cell
(Tregs) responses during influenza infection in obese mice [19–
21,45]; therefore, we focused our immune-metabolic integration
on these cell types in particular. For influenza-specific CD8+ T
Figure 2. Pre-processed 1H NMR urine spectra were analyzed
using PCA and PLS-DA. Urine spectra from lean and obese mice
were collected one day prior to infection and at 2 and 6 dpi. A/B) The
urine spectra from lean mice (A) and obese mice (B) showed clear
separation according to time, in a PCA analysis. C). PLS-DA analysis
showed additional separation between lean and obese mice for two
selected time points (i.e. -1 dpi and 6 dpi). n = 8–9.
doi:10.1371/journal.pone.0097238.g002
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cells, we utilized an MHC class I tetramer specific for H-2Db-
resricted epitope of the influenza nucleoprotein (NP, DbNP366-74)
of PR/8, and CD4+ Tregs were identified by expression of the
transcription factor Foxp3.
The 1H NMR data from each biological compartment (i.e. lung,
liver, WAT, feces, BALF, serum, and urine) were correlated with
BAL and mLN T cell populations at 9 dpi. Urine (6 dpi), lung
(Tables 3 and 4) and liver presented the highest amount of T cell-
metabolite correlations in both lean and obese mice. Interestingly
Table 1. Metabolic biomarkers recovered from urine and fecal extracts during influenza infection in lean and obese micea.
Metabolic Pathway Metabolite Day -1 Day 2 Day 6
Ketone Body Metabolism 3 hydroxybutyrate Urine






Choline Metabolism choline Feces
Microbial Metabolism trimethylamine Urine Urine
Nucleotide Metabolism ureidopropanoate Urine Urine
Vitamin Metabolism ascorbate Urine
1-methylnicotinamide Urine
Carbohydrate Metabolism glucose Urine Urine Urine
UK1 2.458(s) Feces
UK2 8.54(d), 8.33(d), 6.7(d), 6.67(d), 3.65(s) Urine Urine Urine
aBolded and underlined urine and feces indicates that metabolite was significantly higher in obese mice, and metabolites in normal font were significantly lower in
obese mice. UK: unknown metabolite. n = 8–9.
doi:10.1371/journal.pone.0097238.t001
Table 2. Discriminatory metabolites between lean and obese mice at 9 days post-infection in liver, serum and white adipose tissue
samplesa.
Metabolic Pathway Metabolite Liver Serum WAT









Biosynthesis of Secondary Metabolism scyllo-inositol 2
Carbohydrate Metabolism glucose + +
Ketone Body Metabolism acetone 2
3 hydroxybutyrate 2
Lipid Metabolism glycerophosphocholine +
LDL ( = CH-CH2-) +
LDL (-CH = CH-CH2-CH = CH-) +
LDL (CH3) +
Pyruvate Metabolism acetate 2
aMetabolites that were detected at a significantly greater level in obese mice are indicated by +, whereas 2 represents metabolites detected at lower levels in obese
mice compared with lean mice, n = 8–9.
doi:10.1371/journal.pone.0097238.t002
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the correlations were not restricted to the corresponding cellular
compartment but showed systemic links. For example, 3-
hydroxybutyrate in serum negatively correlated with BAL CD4+
T cells in lean mice, whereas urinary 3-hydroxybutyrate positively
correlated with BAL CD4+ T cells in obese mice (Table S1). A
relatively similar pattern of correlations was detected for BAL
Tregs (CD4+CD25+Foxp3+), but 3-hydroxybutyrate in the lungs of
obese mice positively correlated with BAL Tregs (Figure 4,
Table 3). Further, 3-hydroxybutrate in several compartments
correlated with various mLN and BAL CD8+ T cell populations in
lean and obese mice (Table 4 and Table S1). Other metabolites,
such as choline, taurine and creatine from a variety of tissues/
biofluids were found to be significantly associated with several T
cell populations in the lung airways and mLN. A detailed list of
correlative metabolic markers is provided in Tables 3, 4 and S1.
Significant correlations among metabolites and T cell populations
may result from co-variation without indication of a mechanistic
link, but it is also possible that detected correlations reveal
underlying mechanisms directly or indirectly affecting T cell
distribution and function in lean and obese mice.
Conclusion
Globally, 500 million adults are clinically obese, and the
number of pathophysiological complications and identified health
risks of excess adiposity continue to mount [2]. Although a number
of innate and adaptive immune defenses are altered by obesity
during influenza infection, explanatory mechanisms remain
relatively undefined. Through metabolic assessment of urine and
feces, we demonstrated that metabolic profiling can successfully
distinguish uninfected lean and obese mice, naı̈ve and infected
mice, and lean and obese mice infected with influenza. Metabolic
analysis of serum, WAT and livers also revealed differences in a
variety of metabolic pathways in obese mice during the peak of
influenza immune responses. Lastly, statistical relationships
between T cell responses and tissue/biofluid metabolites were
uncovered allowing for a thorough differential immune-metabolic
characterization.
Metabolic profiling of urine and feces revealed greater levels of
urinary taurine, ureidopropanoate, 1-methylnicotinamide, glucose
and fecal choline in uninfected obese mice. Metabolic changes
detected in the urine and feces may reflect local changes in the
kidneys or gastrointestinal system, as well as systemic alterations in
metabolism. To our knowledge, there are currently no reports
defining how influenza infection alters metabolite profiles in the
urine and feces of mice. During infection, acetylcarnitine,
ascorbate, glucose and 3-hydroxybutyrate were elevated in the
urine of obese mice. Of interest, a variety of lipid metabolites and
propionate (a short chain fatty acid) [46] were detected at greater
concentrations in the feces of obese mice at 2 dpi. Because these
changes were not observed prior to infection, the increased levels
of these metabolites are specific to the infection in obese mice (and
not simply due to diet or obesity status). This finding may yield
new hypotheses related to obesity and influenza infection, such as:
Are there local changes in the gastrointestinal system of obese mice
during influenza that may impact infection outcome? Does obesity
induce alterations in the gut microbiota during influenza,
potentially impacting infection responses (propionate can be
produced by gut microbiota) [46]? Further, acetylcarnitine was
detected at higher levels in the urine of obese mice at 6 dpi.
Acetylcarnitine is the acetylated form of carnitine, which is utilized
in fatty acid transport into mitochondria for subsequent b-
oxidation. Therefore, various metabolites related to lipid metab-
olism were significantly altered in the feces and urine of obese
Figure 3. O-PLS-DA analysis comparing serum 1H NMR spectra of lean and obese mice at 9 dpi. n = 8–9.
doi:10.1371/journal.pone.0097238.g003
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mice, perhaps suggesting alterations in lipid metabolism contrib-
utes to differential infection responses in obese mice. Of interest, it
has been demonstrated metabolic profiling of mouse serum
revealed influenza infection alone causes changes in a number of
lipid metabolites [30].
Ascorbate (vitamin C) was significantly higher in the urine of
obese mice at 2 dpi. Excess levels of ascorbate in mice are
controlled, in part, through urinary excretion [47,48]. Unlike
humans, mice have the ability to synthesize endogenous ascorbate
[49,50]. Further, during times of stress, mammals upregulate
ascorbate biosynthesis [51]. Ascorbate fulfills a variety of
physiological functions, including regulation of oxidative stress
[50,52]. Elevated ascorbate in the urine may be indicative of
greater levels of oxidative stress in infected obese mice. Oxidative
stress and vitamin C deficiency in mice can increase influenza
infection pathology and mortality [50,53,54]. Further, influenza
infection and obesity are independently associated with greater
levels of oxidative stress [55,56]. Therefore, it is likely that obesity
exacerbates oxidative stress conditions during influenza infections,
ultimately affecting infection outcome. Further, if vitamin C
requirements are increased during infection in the obese, perhaps
obese humans require greater ascorbate intake during influenza
infection and should supplement during influenza seasons. It is
interesting that ascorbate was detected at greater levels in the urine
of obese mice, but it is unclear why elevated levels weren’t detected
in the serum or the liver (primary site of synthesis). Perhaps, at
9 dpi, when serum and livers were harvested, ascorbate in obese
mice returned to similar levels as in lean mice.
Table 3. Lung metabolite correlation patterns with BAL T cell populationsa.
BAL Cells Lean Obese
Total BAL cell number creatine, glycerol, taurine
CD4+ T cells creatine, glycerol, phosphocholine, taurine
CD4+CD25+ T cells 3-hydroxybutyrate, acetate, alanine,
creatine, glycerol, lactate, phosphocholine, taurine
CD4+CD25+FoxP32 T cells 3-hydroxybutyrate, creatine, glycerol,
lactate, phosphocholine, taurine
CD4+CD25+Foxp3+ T cells 3-hydroxybutyrate, acetate, choline,
creatine, glycerol, lactate, phosphocholine, taurine
3-hydroxybutyrate
CD4+FoxP3+ T cells 3-hydroxybutyrate, acetate, choline,
creatine, glycerol, lactate, phosphocholine, taurine
3-hydroxybutyrate
CD4+FoxP3hi T cells 3-hydroxybutyrate, acetate, choline,
creatine, glycerol, lactate, phosphocholine, taurine
CD8+CD25+ T cells 3-hydroxybutyrate, creatine
CD8+DbNP366-74
+ T cells choline, glycerol
CD8+CD25+DbNP366-74
+ T cells acetate, alanine, choline, creatine,
glucose, glycerol, lactate, leucine, methionine,
phosphocholine, taurine, valine
aUnderlined metabolites represent a significant negative correlation, and text without an underline indicates a significant positive association. Correlation analysis is
based on a Pearson correlation matrix validated by 10,000 permutations. n = 8–9.
doi:10.1371/journal.pone.0097238.t003
Table 4. Lung metabolite correlation patterns with mLN T cell populationsa.
mLN Cells Lean Obese
Total mLN cell number glucose
CD4+ T cells glucose, glycerol
CD4+CD25+Foxp3+ T cells alanine, leucine,
valine
glucose
CD4+Foxp3+ T cells leucine, valine
CD4+Foxp3hi T cells glucose
CD8+ T cells 3-hydroxybutyrate, glucose, glycerol
CD8+DbNP366-74
+ T cells 3-hydroxybutyrate, acetate, alanine, choline, creatine,
glucose, glycerol, lactate, leucine, methionine, phosphocholine, valine
CD8+CD25+DbNP366-74
+ T cells 3-hydroxybutyrate, acetate, alanine, choline, creatine,
glucose, glycerol, lactate, leucine, methionine, taurine, valine phosphocholine
aUnderlined text represents a significant negative correlation, and text without an underline indicates a significant positive association. Correlation analysis is based on a
Pearson correlation matrix validated by 10,000 permutations. n = 8–9.
doi:10.1371/journal.pone.0097238.t004
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Another interesting finding revealed by metabolic profiling was
that glucose was significantly elevated in the urine of obese mice
prior to infection, and at 2 and 6 dpi. Glucose intolerance often
results in glucosuria [42,57]. Further, obese mice had greater levels
of glucose in the serum and liver at 9 dpi compared with lean
mice. It has been extensively demonstrated that diet-induced and
genetic obese mice exhibit elevated blood glucose levels [58,59].
However, tissue and circulating glucose levels in obese mice have
never been measured during the context of an influenza infection.
Chronically elevated glucose can have a variety of pathological
effects, including glycation products, oxidants, hyperosmolarity
and perturbations in cell signaling pathways [59]. Therefore, it
would be interesting to investigate influenza severity in a model in
which obese mice have normalized insulin sensitivity and glucose
tolerance [28].
In recent years, an abundance of research has focused on how
metabolism is a critical regulator of immune cell function [60].
Manipulation of nutrient availability in culture or genetic
manipulation of genes that regulate metabolic pathways can have
a profound impact on immune activity and disease outcome
[4,60]. However, it is relatively unclear how metabolites and
nutrients in the immune cell microenvironment may alter cellular
metabolism, distribution and function during the context of an
infection. Therefore, we took advantage of this comprehensive
metabolic analysis and assessed significant interactions between T
cell populations and metabolites. A number of immune-metabolic
correlations were uncovered. For example, lung choline and
phosphocholine were positively associated with BAL Tregs and
other CD4+ T cell populations in lean mice but not in obese mice.
Perhaps, perturbations in choline/phosphocholine metabolism
may impact T cell responses in obese mice. These findings could
be indicative of direct or indirect T cell-metabolite interactions,
although it is also possible that these associations are biologically
insignificant. Nonetheless, identification of BAL and mLN T cell-
metabolite correlates provides a more dynamic and global
assessment of the consequences of obesity during influenza
infection.
The urinary and fecal data are particularly interesting given the
non-invasive nature of these bio-samples and the high degree of
separation detected between naı̈ve and infected, lean and obese
mice. Numerous reports have established metabolic profiling of
urine can identify biomarkers and metabolic matrices that can
distinguish disease states, with the capability of ultimately guiding
treatment [61–63]. At 2 dpi, prior to significant weight loss and
any obvious signs of sickness, we identified a unique metabolic
fingerprint in the urine and feces of influenza infected obese mice,
consisting of perturbations in lipid, nucleotide, carbohydrate,
microbial, and vitamin metabolism. Given the rapidity of
influenza transmission during epidemics and pandemics and the
sudden onset of severe symptoms in infected individuals [14],
identification of a metabolic profile unique to an early infection
time point holds widespread implications for personal and public
health. We have identified a metabolic signature that could be
used to predict influenza infection status even prior to any obvious
signs of illness. Further testing can determine if this signature is
unique to influenza infection rather than a generalized response to
an infection or inflammation.
Taken together, this investigation establishes metabolic profiling
as a useful tool for characterizing infection responses during
influenza and identifying potential pathways and mechanisms
contributing to altered immunity in obese mice. Teasing apart
differential responses during influenza infection is key to under-
Figure 4. Correlation analysis of lung 1H NMR data and T cell populations in BALF (left panel) and mLN compartments (right panel)
reveals differential correlation patterns between lean and obese mice. n = 8–9.
doi:10.1371/journal.pone.0097238.g004
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standing the mechanisms driving greater disease severity in obese
mice compared with lean mice. Further utilization of metabolic
profiling as a complimentary tool to immunological measures of
infection outcome could help advance the current knowledge of
the response to influenza infection in other rodent research models
and may have potential applications in clinical and research
settings.
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